Sign in

The Sick Times

@thesicktimes.org
33K followers 288 following 820 posts

Award-winning nonprofit news site chronicling the #LongCOVID crisis. Founded by @BetsyLadyzhets.bsky.social & @MilesWGriffis.bsky.social Website: thesicktimes.org Newsletter: thesicktimes.org/newsletter Donate: the-sick-times.fundjournalism.org

PostsRepliesMedia
The Sick Times @thesicktimes.org · 22h
While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to medical care. Read more from @octoberk.bsky.social: thesicktimes.org/2026/09/29/i...
A graphic shows two images side by side. One are mobility devices, including many walkers, outside of prison cells. Another shows a red SARS-CoV-2 virus contrasted with a black background. The text reads, “The Sick Times. I interviewed five people with Long COVID in prison. They are invisible in the system. By October Krausch. Meanwhile, her cellmate, Wayland Scott, says he has frequently had problems breathing after COVID-19, and gets winded going up the stairs he must take to get to his cell. Even so, he has not been able to receive an inhaler, despite having one before Long COVID when he first came to prison. “There was a year that they had a big shortage of the albuterol. And when that happened, I got taken off of my inhaler and I’ve never been able to get it back,” he said.
05421
The Sick Times @thesicktimes.org · 29/09/2026
To stay up to date with the latest COVID-19 trends, make sure you're signed up for our newsletter! You'll get @betsyladyzhets.bsky.social's breakdown every Tuesday, delivered directly to your inbox! thesicktimes.org/newsletter/
The CDC’s infectious disease forecasting center, which uses emergency department data, estimates that COVID-19 cases are “growing or likely growing” in 14 states, “declining or likely declining” in five states, and “not changing” in 18 states as of September 23.
The West coast remains a major hotspot for COVID-19 spread as it’s been throughout the summer. The CDC describes average SARS-CoV-2 levels in wastewater as “high” for California, Oregon, and Washington and “very high” for Hawaii; what the CDC calls “high,” I would characterize as actually very high given the agency’s high baseline for this metric.Levels might be declining in some parts of the West but are still going up in others.
COVID-19 levels in the South seem to be on the decline, but remain higher as this region has also been a hotspot this summer.
The Northeast might be the next hotspot, with wastewater as well as healthcare system data reporting potential increases.This week, the CDC’s wastewater dashboard includes a note that data will be interrupted for about 200 testing sites. The note describes this as a “brief gap” in data while the agency awards a new contract to a biotech company that will supplement testing programs at state and local public health departments.
While the CDC says there will be a “brief gap” in data from these sites, it doesn’t provide any specifics on when a new contract will be awarded or how the agency will support places impacted by this break in testing. My story from last June includes more context on this situation.
062
The Sick Times @thesicktimes.org · 29/09/2026
The current COVID-19 picture remains varied by region: as the summer wave continues into early fall, cases are trending up in the Northeast and parts of the West and down in the South. And an upcoming gap between CDC contracts will further restrict available data. thesicktimes.org/2026/09/29/n...
Graphic from The Sick Times sharing the latest COVID-19 trends for September 29, 2026. The graphic presents trends for three metrics: WastewaterSCAN category for SARS-CoV-2, which is "high" (represented with red) and slightly decreasing (represented with a diagonal down arrow); CDC wastewater viral activity level for SARS-Cov-2, which is "low*" (darker yellow) and stable (side to side arrow); and CDC COVID-19 test positivity, which is moderate (darker yellow) and slightly decreasing. Text below these metrics reads: "*CDC wastewater viral activity levels are calculated based on measurements in the last two years only. They do not account for the lower spread that could be possible with more widespread precautions."

The current COVID-19 picture remains varied by region: as the summer wave continues into early fall, cases are trending up in the Northeast and parts of the West and down in the South. And an upcoming gap between CDC contracts will further restrict available data.
12413
Reposted by The Sick Times
betsy ladyzhets 😷 @betsyladyzhets.bsky.social · 29/09/2026
Really proud to publish this piece by @octoberk.bsky.social on Long COVID in prisons. "All those who spoke to @thesicktimes.org lacked Long COVID–informed medical care, but more than that, they lacked access to basic information about the disease." thesicktimes.org/2026/09/29/i...
thesicktimes.org
I interviewed five people with Long COVID in prison. They are invisible in the system. - The Sick Times
While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to me...
16522
Reposted by The Sick Times
Miles W. Griffis @mileswgriffis.bsky.social · 29/09/2026
"John Richard Green, who is imprisoned in Texas, wrote that, w/ Long COVID, his health is “more messed up than the floor of a New York cab...Now I am bedbound, sick, and all alone." Vital feature by @octoberk.bsky.social about the disease's invisibility in prison. thesicktimes.org/2026/09/29/i...
thesicktimes.org
I interviewed five people with Long COVID in prison. They are invisible in the system. - The Sick Times
While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to me...
16335
Reposted by The Sick Times
october "pre-order The Struggle Is Always Worth It now!" krausch @octoberk.bsky.social · 29/09/2026
this investigation on long COVID inside of prisons is out today at the Sick Times! I worked on this piece for months and am so grateful to the folks who shared their experiences with me. I'll write up a real thread a little later, but you can read it now: thesicktimes.org/2026/09/29/i...
thesicktimes.org
I interviewed five people with Long COVID in prison. They are invisible in the system. - The Sick Times
While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to me...
415181
Reposted by The Sick Times
Heather Hogan @heatherhogan.bsky.social · 26/09/2026
It would be so cool if you would take this survey! Instagram is right on your tail with their engagement in our survey, Bluesky! Come on now, don't let META beat you!!!!
0208
The Sick Times @thesicktimes.org · 26/09/2026
We want to hear from you and understand how you engage with The Sick Times. Please take this quick survey to let us know what you think: www.surveymonkey.com/r/SS6ZH8S
A black background with white text reads, “If you have 5 minutes, we’d love your feedback on our Long COVID journalism. What do you say? Take the survey. The Sick Times.”
03113
Reposted by The Sick Times
colin feral @sal.gay · 26/09/2026
A great time to revisit this piece by @mileswgriffis.bsky.social!
them.us
These Are the Drag Artists and Organizers Fighting to Make Queer Spaces More COVID Safe
Air purifier lending libraries, mask blocs, and mutual aid initiatives are just a few of the ways activists are making spaces where LGBTQ+ people gather more COVID-safe.
210534
The Sick Times @thesicktimes.org · 25/09/2026
Study: More evidence of reduced blood flow to the brain of people with Long COVID Analysis: The U.S. is ill-equipped to respond to LC and future mass disabling events Preprint: Assessed over 700 LC clinical trials and found that they emphasized treating symptoms thesicktimes.org/2026/09/22/r...
A visual shows functional magnetic resonance imaging (fMRI) of the brain, which allow researchers to visualize the activity of the brain. Three scans surround a 3-d image of a human head with a view into their brain. The text reads, “The Sick Times. Long COVID research updates. A small study found more evidence of reduced blood flow to the brain of people with Long COVID. New analysis: The U.S. is ill-equipped to respond to Long COVID and future mass disabling events. A recent preprint assessed over 700 Long COVID clinical trials and found that they emphasized treating symptoms.” A small study in NeuroImage: Reports has found more evidence of reduced blood flow to the brain of people with Long COVID. The authors concluded that this abnormality was linked with fatigue, after they assessed brain imaging results of 22 people with Long COVID and compared them with 19 controls. Participants of the study performed a 20-minute cognitive test called psychomotor vigilance task (PVT), while undergoing a type of MRI that tracks blood flow. People with Long COVID reported much higher fatigue than controls both before and after the task, and “exhibited significantly longer reaction times during the PVT,” the authors concluded.
The U.S. is ill-equipped to respond to Long COVID and future mass disabling events, a new analysis argues in The Journal of Medical Humanities. Author Philip Finkelstein evaluated the disease through the lens of securitization, or, how public challenges are viewed as existential security threats. He found that modern security strategies remain “shortsighted and poorly attuned to threats that operate insidiously, eroding societies from within.” He stated that to properly address the security of Long COVID on society, the U.S. would need to invest in long-term care, workplace accommodations, and social support, but that these solutions are not “geopolitically advantageous.” 
A recent preprint shared in Research Square assessed over 700 Long COVID clinical trials and found that they emphasized treating symptoms. Only 57 of the 714 trials addressed post-exertional malaise (PEM), prevalent in a subtype of Long COVID, and only eight of those trials used PEM as primary endpoint. “There is a substantial unmet need for well-powered, mechanism-based, disease-modifying trials with biomarker-driven designs and objective, exertion-based endpoints,” the researchers concluded. Still, researchers stated they used a conservative research strategy, which may have missed some studies.
28233
The Sick Times @thesicktimes.org · 24/09/2026
1,700 people have signed a petition asking for a pause and independent review of a Long COVID trial planning to test the Lighting Process, a pseudoscientific mind-body program that outside experts have heavily criticized. Read more from spichaksimon.bsky.social: thesicktimes.org/2026/09/22/p...
A close up of a grey stone building at McMaster University. Ivy crawls across the building, changing color in fall. It appears green, orange, and red. The text reads, “The Sick Times. People with Long COVID demand pause of McMaster University clinical trial. By Simon Spichak. Reporting.” Key points you should know:

A petition signed by 1,700 people asks for a pause and independent review of a trial run by McMaster University researchers who want to test the Lightning Process.
 
The Lightning Process is a pseudoscientific mind-body program to try to treat Long COVID that has been accused of exploiting people with Long COVID and related diseases.
 
The trial is designed in part by a Lightning Process practitioner and prescreens participants for motivation using a questionnaire that isn’t validated for Long COVID.
 
There are very few trials and little funding in Canada for Long COVID research, and advocates believe that studying the Lightning Process instead of pathobiological pathways is a waste of funding.
26415
The Sick Times @thesicktimes.org · 24/09/2026
Thank you, Sarah! 💜
010
The Sick Times @thesicktimes.org · 24/09/2026
We need your help! Please take this quick survey and tell us how we’re doing. www.surveymonkey.com/r/SS6ZH8S
The Sick Times

How are we doing?

Take our annual audience survey to let us know how we’re doing and be entered to win a Sick Times hat!

Are you in? 

Take the survey.
1135
The Sick Times @thesicktimes.org · 23/09/2026
Thank you! 💜
010
Reposted by The Sick Times
Maria Christou @mariacervin.bsky.social · 23/09/2026
Congratulations @thesicktimes.org 🥳
1121
Reposted by The Sick Times
samantha riedel @samanthawrites.net · 23/09/2026
"Disability activists warned for years that this would be the outcome of allowing COVID-19 to spread unmitigated. Now that it’s time to pay the piper, the state and its media allies are working desperately to sever the connection between COVID-19 and its consequences."
116382
Reposted by The Sick Times
Miles W. Griffis @mileswgriffis.bsky.social · 23/09/2026
NEW ⭐: The Sick Times is listed as a finalist in NASW's Journalism Awards for our story on axed RECOVER grants for #LongCOVID. We're so proud of our small publication; Congrats to all the finalists and winners from ProPublica, NYT, the Guardian, Science, and others! www.nasw.org/2026Sciencei...
nasw.org
Announcing the 2026 NASW Science in Society Journalism Award winners
The National Association of Science Writers and its Awards Committee are pleased to announce the winners of the <strong>2026 NASW Science in Society Journalism Awards.</strong> This year, NASW is awar...
57020
The Sick Times @thesicktimes.org · 23/09/2026
The Telegraph recently published an article about "sickfluencers" titled “How having a disability became cool." We've republished a piece by Julia Doubleday at The Gauntlet pushing back against the article, which she calls "absurd on its face." thesicktimes.org/2026/09/21/c...
A young woman stands by a staircase with a backdrop of tree canopy.  She wears a white, high quality mask and has long dark hair. She wears a teal sweatshirt and black pants. The text reads, “The Gauntlet x The Sick Times. COVID-19 — not TikTok — is disabling young women “Sickfluencers” are symptoms of a mass disabling event. By Julia Doubleday.” “The country is sicker than it’s ever been before” — now why would that be? Six years after COVID-19 hit, four years after the virus has been allowed to run totally rampant without mitigation, the country is sicker than it’s ever been before, but we can’t come up with any reason why that would be other than “women be faking?”
313644
Reposted by The Sick Times
Simon Spichak @spichaksimon.bsky.social · 23/09/2026
For @thesicktimes.org, I covered a petition that over 1,700 people have signed calling for a pause to a trial that's applying for ethical approval to test a psuedoscientific program for #LongCOVID called The Lightning Process. thesicktimes.org/2026/09/22/p... 1/n
Screenshot of Sick Times article. Title: "People with Long COVID demand pause of McMaster University clinical trial"

DEK: The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.

Image: A college buildingey points you should know:

A petition signed by 1,700 people asks for a pause and independent review of a trial run by McMaster University researchers who want to test the Lightning Process.
 
The Lightning Process is a pseudoscientific mind-body program to try to treat Long COVID that has been accused of exploiting people with Long COVID and related diseases.
 
The trial is designed in part by a Lightning Process practitioner and prescreens participants for motivation using a questionnaire that isn’t validated for Long COVID.
 
There are very few trials and little funding in Canada for Long COVID research, and advocates believe that studying the Lightning Process instead of pathobiological pathways is a waste of funding.
13013
Reposted by The Sick Times
Am Chima @ace9801.bsky.social · 23/09/2026
Thank you @spichaksimon.bsky.social for this fantastic article highlighting the “bogus quackery” that continues to surface in this landscape. And thank you to @thesicktimes.org for your part in making this happen. #LongCOVID #PAIS #IACCIs #MEcfs #pwME thesicktimes.org/2026/09/22/p...
thesicktimes.org
People with Long COVID demand pause of McMaster University clinical trial - The Sick Times
The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.
1154
The Sick Times @thesicktimes.org · 22/09/2026
To stay up to date with the latest COVID-19 trends, make sure you're signed up for our newsletter! You'll get @betsyladyzhets.bsky.social's breakdown every Tuesday, delivered directly to your inbox! thesicktimes.org/newsletter/
In the South, wastewater and healthcare system data both indicate decreasing COVID-19 cases. The CDC’s infectious disease forecasting center estimates cases are “declining or likely declining” in 13 states as of September 16, including states across the South.
In the West, there are conflicting data on whether the wave has peaked or is still rising. The CDC’s regional average for the West reports a decline, while WWSCAN reports a plateau or slower increase and Biobot Analytics reports a significant increase.
Still, recent COVID-19 levels are higher across both the South and West.Chart from the CDC's Center for Disease Forecasting and Outbreak Analytics (CFA) displaying recent epidemic trends for COVID-19. The chart is a map of the U.S. with states color-coded according to their COVID-19 trend status: dark purple for "growing" cases, lighter purple for "likely growing," white for "not changing," gray for "not estimated," lighter teal for "likely declining," and darker teal for "declining." Text above the chart reads: "As of September 16, 2026, we estimate that COVID-19 infections are growing or likely growing in 27 states, declining or likely declining in 13 states, and not changing in 10 states. Previous estimates can be found on data.cdc.gov." The states with "growing or likely growing" cases are largely all in the North of the U.S. (plus California, Alaska, and Hawaii) and states with "declining or likely declining" cases are all in the South.

The Northeast, and to a lesser extent the Midwest, are starting to report increasing COVID-19 spread after lower levels throughout the summer. The CDC’s forecasting center estimates cases are “growing or likely growing” in 27 states, with most of those in the Northeast, Midwest, and Northwest.As updated COVID-19 vaccines have started to become available, some health experts are raising concerns about their status in the CDC’s Vaccines for Children program, which provides free vaccinations to children who are uninsured, underinsured, or otherwise need financial support. The agency hasn’t yet decided whether COVID-19 vaccines will be part of the program this year, the Wall Street Journal reported last week. Delaying or restricting COVID-19 vaccines from this program could lead to increased severe infections and Long COVID among children.
0133
The Sick Times @thesicktimes.org · 22/09/2026
COVID-19 spread seems to have peaked for the summer in the South, but may still be increasing in the West and is starting to go up more in Northern states. thesicktimes.org/2026/09/22/n...
Graphic from The Sick Times sharing the latest COVID-19 trends for September 22, 2026. The graphic presents trends for three metrics: WastewaterSCAN category for SARS-CoV-2, which is "high" (represented with red) and slightly increasing (represented with a diagonal up arrow); CDC wastewater viral activity level for SARS-Cov-2, which is "low*" (darker yellow) and stable (side to side arrow); and CDC COVID-19 test positivity, which is moderate (darker yellow) and slightly decreasing (diagonal down arrow). Text below these metrics reads: "*CDC wastewater viral activity levels are calculated based on measurements in the last two years only. They do not account for the lower spread that could be possible with more widespread precautions."

While national averages for COVID-19 metrics appear to be at a peak or plateau as of mid-September, the picture actually looks pretty different from region to region. COVID-19 spread seems to have peaked for the summer in the South, but may still be increasing in the West and is starting to go up more in Northern states.
15122
Reposted by The Sick Times
Miles W. Griffis @mileswgriffis.bsky.social · 22/09/2026
Over 1,700 people have signed a petition calling on McMaster University to review a Long COVID clinical trial evaluating a pseudoscientific "mind body" program. "It seems like we're in the dark ages," the petition author told @spichaksimon.bsky.social thesicktimes.org/2026/09/22/p...
thesicktimes.org
People with Long COVID demand pause of McMaster University clinical trial - The Sick Times
The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.
37732
Reposted by The Sick Times
betsy ladyzhets 😷 @betsyladyzhets.bsky.social · 22/09/2026
Today @thesicktimes.org: People with Long COVID are demanding a pause and review for a planned clinical trial that would test the Lightning Process, a pseudoscientific mind-body treatment. By @spichaksimon.bsky.social: thesicktimes.org/2026/09/22/p...
thesicktimes.org
People with Long COVID demand pause of McMaster University clinical trial - The Sick Times
The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.
38037
Reposted by The Sick Times
Miles W. Griffis @mileswgriffis.bsky.social · 21/09/2026
"Now that it’s time to pay the piper, the state and its media allies are working desperately to sever the connection between COVID-19 and its consequences." Julia Doubleday takes down an ableist Telegraph column that denies the reality of Long COVID. thesicktimes.org/2026/09/21/c...
thesicktimes.org
COVID-19 — not TikTok — is disabling young women - The Sick Times
The Telegraph published an article titled, “How having a disability became cool." This article shores up the government narrative that rising rates of disability are being driven, not by the ongoing a...
318669
Reposted by The Sick Times
betsy ladyzhets 😷 @betsyladyzhets.bsky.social · 21/09/2026
Today @thesicktimes.org: We republished a recent piece by Julia Doubleday at The Gauntlet, pushing back on a much-derided ableist article in The Telegraph. "The state and its media allies are working desperately to sever the connection between COVID-19 and its consequences."
thesicktimes.org
COVID-19 — not TikTok — is disabling young women - The Sick Times
The Telegraph published an article titled, “How having a disability became cool." This article shores up the government narrative that rising rates of disability are being driven, not by the ongoing a...
012764
Reposted by The Sick Times
Heather Hogan @heatherhogan.bsky.social · 21/09/2026
Help us get better!
0154
Reposted by The Sick Times
Miles W. Griffis @mileswgriffis.bsky.social · 21/09/2026
We’re always looking for ways to improve our work at The Sick Times. Please help us by filling out this short survey to help us learn more about our readers and how we can make our publication even better 🙏🏼
0155
The Sick Times @thesicktimes.org · 21/09/2026
We want to know how you feel about the job we’re doing at The Sick Times. Please help us by taking this quick survey: www.surveymonkey.com/r/SS6ZH8S
A black background with white text reads, “If you have 5 minutes, we’d love your feedback on our Long COVID journalism. What do you say? Take the survey. The Sick Times.”
12814
Reposted by The Sick Times
Marushka-T @marushka-t.bsky.social · 17/09/2026
When climate collapse and a pandemic response are managed by capitalism, not science. #COVID #capitalism #pandemic #publichealth #climatecollapse
03513
The Sick Times @thesicktimes.org · 18/09/2026
Want to stay on top of all the latest Long COVID research? Sign up for our newsletter and get @mileswgriffis.bsky.social's research updates delivered directly to your inbox every Tuesday! thesicktimes.org/newsletter/
Read Miles W. Griffis’ Long COVID research updates. 

thesicktimes.org

And sign up for our newsletter to get Miles’ weekly research updates delivered directly to your inbox!

thesicktimes.org/newsletter
0125
The Sick Times @thesicktimes.org · 18/09/2026
🦠 Study: Repeat SARS-C0V-2 infections were linked to a higher odds of new health conditions 📝 Long COVID, myalgic encephalomyelitis, and post-treatment Lyme disease are included as priorities in the new NIAID 2026-2030 Strategic Plan thesicktimes.org/2026/09/15/r...
A colorful red, orange, and purple microscopic image shows coronavirus particles in vibrant detail. The text reads, “The Sick Times. Long COVID research updates. Study: Repeat SARS-C0V-2 infections were linked to a higher odds of new health conditions. Long COVID, myalgic encephalomyelitis, and post-treatment Lyme disease are included as priorities in the new NIAID 2026-2030 Strategic Plan.” Repeat SARS-C0V-2 infections were linked to a higher odds of new health conditions, according to a new study in the Canada Communicable Disease Report. Researchers assessed data from 9,000 people who responded to a self-reported survey between 2020 and 2023, and found that those with more than two SARS-CoV-2 infections had a 76% higher risk of a new diagnosis compared to those who had not reported any infections. The survey covered a broad range of diagnoses, including respiratory, cardiovascular, neurological, and musculoskeletal conditions. The authors cautioned that the results could not prove that SARS-CoV-2 infection caused the new conditions due to limitations of the study.
Long COVID, myalgic encephalomyelitis, and post-treatment Lyme disease are included as priorities in the new NIAID 2026-2030 Strategic Plan. The National Institute of Allergies and Infectious Diseases claims it will center on finding both risk factors and underlying mechanisms.“NIAID remains committed to supporting research to develop person-centered prevention and treatment strategies that improve the quality of life of those impacted by long-term conditions following clearance of an infection,” the plan states. Still, it’s unclear how NIAID plans to fund additional research for these diseases.
35118
The Sick Times @thesicktimes.org · 17/09/2026
This week at The Sick Times, Selina Nwulu argues that corporate interests have had more say in our behaviors toward both COVID-19 and the climate crisis than any evidence-based public health response. thesicktimes.org/2026/09/15/d...
A demonstrator holds a cardboard sign that reads  "People Not Profit". The demonstrator has long hair and wears a high quality black mask. The text reads, “The Sick Times. Denial is a tactic for both the COVID-19 and climate crises. By Selina Nwulu. Commentary.” Corporate influences in today’s age don’t look like outright denial; instead, leaders insist on the smoke and mirrors of “business as usual.” 
Living in this denial, and subsequent neglect, is catastrophic on both a practical and existential level. What does it do to our sense of self and safety to be routinely gaslit out of reacting in real time to the crises that surround us?
05827
Reposted by The Sick Times
Miles W. Griffis @mileswgriffis.bsky.social · 16/09/2026
"Mainstream outlets have published misinformation on Long COVID, calling it [psychosomatic] despite the plethora of research that proves it’s a biological disease. This parallels climate nonexperts questioning climate change’s seriousness and calling it a “hoax.”" thesicktimes.org/2026/09/15/d...
thesicktimes.org
Denial is a tactic for both the COVID-19 and climate crises - The Sick Times
Corporate interests have had more say in our behaviors toward both COVID-19 and the climate crisis than any evidence-based public health response.
212348
The Sick Times @thesicktimes.org · 16/09/2026
This summer’s COVID-19 wave may have reached its peak in some parts of the country, as major metrics report disease levels stagnating or starting to decline as of early September. But levels remain high in many places, particularly in the West and South. thesicktimes.org/2026/09/15/n...
Graphic from The Sick Times sharing the latest COVID-19 trends for September 15, 2026. The graphic presents trends for three metrics: WastewaterSCAN category for SARS-CoV-2, which is "high" (represented with red) and stable (represented with a side to side arrow); CDC wastewater viral activity level for SARS-Cov-2, which is "very low*" (lighter yellow) and stable; and CDC COVID-19 test positivity, which is moderate (darker yellow) and stable. Text below these metrics reads: "*CDC wastewater viral activity levels are calculated based on measurements in the last two years only. They do not account for the lower spread that could be possible with more widespread precautions." Wastewater data from the CDC and Biobot Analytics report that national averages of SARS-CoV-2 in sewage have leveled off in recent weeks. WastewaterSCAN still reports an increasing national average through early September, but the rate of that increase has slowed down a lot compared to the rapid climb reported in August.

The West and South have reported the highest SARS-CoV-2 levels in wastewater throughout this wave. In the West, wastewater data from both WWSCAN and Biobot suggest that COVID-19 outbreaks may still be growing in some places.Based on wastewater data, this summer’s wave appears to have included fewer COVID-19 cases than prior summers’. However, such comparisons always need to come with a large grain of salt, because scientists don’t have a great sense of how the coronavirus’ continued evolution, as well as the many other factors that make wastewater data messy, has impacted the way individual infections show up in sewage.

While the COVID-19 wave may be peaking, other viruses are slowly starting to enter the picture.The CDC’s flu surveillance network reports growing cases of influenza-like illness, or people seeking healthcare for fever plus cough or sore throat, over recent weeks. This is a broad metric that can include some COVID-19 cases along with flu, RSV, and other viruses that cause similar respiratory symptoms.
03313
The Sick Times @thesicktimes.org · 15/09/2026
Want to stay on top of more Long COVID clinical trials and breaking news like this? Sign up for The Sick Times newsletter: thesicktimes.org/newsletter/
The novel drug bezisterim may help improve fatigue, post-exertional malaise, and neurological symptoms in people with Long COVID, according to preliminary clinical trial results that the treatment’s developer, BioVie, shared Tuesday morning. While the trial’s findings require further analysis and peer-review, the initial results are among the most promising from any Long COVID trial reported so far, the study’s expert advisors said.

BioVie plans to use these results from its phase 2 trial, called ADDRESS-LC, to inform a larger, phase 3 study that could confirm the drug’s ability to help people with Long COVID. The company also seeks to pursue accelerated Food and Drug Administration (FDA) approval, representatives said during a webinar discussing the results.

Bezisterim is a novel drug also being tested for Parkinson’s and Alzheimer’s diseases. The drug is a synthetic derivative of a steroid and can cross the blood-brain barrier, which means it can directly impact the brain and change neurological symptoms. BioVie states that the drug is believed to reduce inflammation and improve insulin sensitivity.
0164
The Sick Times @thesicktimes.org · 15/09/2026
Novel drug bezisterim may help improve fatigue, post-exertional malaise, and neurological symptoms in people with Long COVID, according to preliminary clinical trial results that the treatment’s developer, BioVie, shared this morning. thesicktimes.org/2026/09/15/b...
ID: A hand placing a pill in a weekly organizer. The text reads, “The Sick Times. Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results. By Betsy Ladyzhets. News.” The following slides feature quotes from the story at The Sick Times. 

“What really stands out to me about the data that have been presented today is that it shows a very clear direction” toward improving key symptoms, said Ezra Spier, a Long COVID patient-researcher who advised the trial team, during the webinar. “It gives the community some hope, because we’ve been seeing trial fail after fail after fail. Seeing something that provides demonstrated impact, I think is really exciting.”
312456
Reposted by The Sick Times
betsy ladyzhets 😷 @betsyladyzhets.bsky.social · 15/09/2026
NEW: Novel drug bezisterim might help with fatigue, PEM, and neurological symptoms in Long COVID, according to preliminary results BioVie shared today. These are early findings that will need more review, but it's exciting to see a positive trial result for once! More @thesicktimes.org:
thesicktimes.org
Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results - The Sick Times
While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial.
39847
Reposted by The Sick Times
Miranda 🌸 @crookedneighbor.bsky.social · 14/09/2026
Oh also everyone please go read this impossibly beautiful essay by @mileswgriffis.bsky.social, which captures the massive losses of the last 6+ years against the visceral backdrop of climate grief. Truly one of the best pieces of writing that I've read in years, and I hope it will be widely shared.
13112
Reposted by The Sick Times
Annette Parde-Maass @netlibrarian.bsky.social · 12/09/2026
“When one neurologist told me I was “just depressed and anxious,” I finally said, “We’re going to stop the gaslighting right now.””
04311
Reposted by The Sick Times
Heather Hogan @heatherhogan.bsky.social · 08/09/2026
I've read this at least five times now and cried every single time. @mileswgriffis.bsky.social has the most beautiful heart.
2446
Reposted by The Sick Times
Robin Hoshiko @robinoliver.bsky.social · 08/09/2026
This is one of my favorite places in the world and I love to see the care and effort put into memorializing something most wish to move on from while doing material good here and now
0144
Reposted by The Sick Times
Miles W. Griffis @mileswgriffis.bsky.social · 08/09/2026
I wrote about an (informal) memorial I made in a burn scar that killed 1.3 million Joshua trees, nearly the same “official” U.S. death toll of the pandemic. Now, I plant the yuccas in remembrance of those who died of Long COVID and ME 🪾🪏 thesicktimes.org/2026/09/08/w...
thesicktimes.org
We made a COVID-19 memorial in the ashes of a Joshua tree forest - The Sick Times
Despite nearly 1.3 million deaths and counting, there is still not a national memorial for the pandemic. Our informal memorial in the middle of the Mojave Desert is one small way to remember those we’...
57930
The Sick Times @thesicktimes.org · 08/09/2026
As @mileswgriffis.bsky.social and his husband participated in the effort to rehabilitate the burn scar from the 2020 Dome Fire, the ritual of planting the Joshua trees took on an even greater meaning when he realized the uncanny overlaps with the COVID-19 pandemic. thesicktimes.org/2026/09/08/w...
Black text over an image of the Dome Fire burn scar reads, “After a lightning bolt hit the forest in August 2020, igniting the fire, Cima Dome became forever bound to the COVID-19 pandemic for me. It was the year I lost both my health and my refuge. Things only got worse in 2023, when a second fire broke outignited in the preserve, burning nearly 100,000 acres and killing another 1 million Joshua trees. Where do you mourn when your sanctuary suddenly becomes a place to grieve? Miles W. Griffis, The Sick Times.” Black text over an image of the Dome Fire burn scar reads, “Because I lost my abilities to the pandemic, this wild gardening has given me some control to confront two crises at once. I plant Joshua trees and leave out water for our nonhuman neighbors to offer mutual aid for the environment. I name each tree to oppose our society’s denial of the pandemic’s “incalculable” mass death and its continuing effects. I imagine each Joshua tree as a spiked fist rising from the ashes of indifference. Miles W. Griffis, The Sick Times.” 
16626
The Sick Times @thesicktimes.org · 03/09/2026
Want to stay on top of Long COVID research and news about clinical trials? Sign up for The Sick Times newsletter and we'll deliver our original reporting directly to your inbox! pages.viral-loops.com/share-the-si...
People with Long COVID are at a higher risk for cardiovascular, renal, and pulmonary (CRP) outcomes, according to a large observational study published in Journal of the American Heart Association. The study was a retrospective study and assessed more than 2.6 million people who developed COVID-19, comparing about 158,000 people who had been diagnosed with Long COVID with the larger group of controls. Researchers assessed 15 types of CRP outcomes including pulmonary embolisms, strokes, kidney disease, and more. They found a greater risk of worse outcomes with Long COVID for younger people compared to younger people without Long COVID, than the differences in risks for older people. 
NASEM recently announced a new study on the impact of SARS-CoV-2 infection across all age groups and its implications for the military. The National Academies of Sciences, Engineering, and Medicine study will specifically assess the scientific evidence of neurocognitive impacts, as well as how the infection affects “military force readiness.” The committee currently has 14 provisional appointees, who will do literature reviews and conduct public meetings on COVID-19 and Long COVID to produce a report for the government. Public feedback is open on the project and committee members until September 14th. 
A new trial for myalgic encephalomyelitis (ME) will study Intermittent Hypoxia-Hyperoxia Treatment (IHHT). Researchers at Aarhus University in Denmark will enroll 104 female participants in the randomized trial and compare the treatment, which delivers short cycles of low and high oxygen for 22–40 minute sessions, to a placebo. They hypothesize that the treatment may help the body adapt to oxygen related stress. The study will use the Short Form-36 Health Survey as its primary endpoint, measuring quality of life. The study is not yet recruiting.
Researchers behind RECOVER-VITAL, the National Institutes of Health’s clinical trial testing Paxlovid for Long COVID, have formally published their results in  The Lancet Infectious Diseases, after sharing them on clinicaltrials.gov this spring. The study found that both 15-day and 25-day Paxlovid courses did not help improve symptoms. While the study collected samples from participants to investigate how the antiviral impacted potential viral persistence, analysis of those samples is “pending” and “will be published” in future studies, the researchers wrote. For more on these results and other RECOVER trials, see Betsy’s story from May.
094
The Sick Times @thesicktimes.org · 03/09/2026
This week's #LongCOVID research updates from @mileswgriffis.bsky.social: thesicktimes.org/2026/09/01/r...
A scanning electron micrograph (SEM) image shows a blood clot, made up of blood cells tangled in grey appearing fibrin. The text reads, "The Sick Times. Long COVID research updates. 

Study: People with Long COVID are at a higher risk for cardiovascular, renal, and pulmonary outcomes

NASEM announced a new study on the impact of SARS-CoV-2 infection across all age groups and its implications for the military

A new trial for myalgic encephalomyelitis will study Intermittent Hypoxia-Hyperoxia Treatment 

RECOVER-VITAL’s clinical trial testing Paxlovid for Long COVID has formally published their results
13213
Reposted by The Sick Times
Heather Hogan @heatherhogan.bsky.social · 02/09/2026
Another home run from @betsyladyzhets.bsky.social!
0175
The Sick Times @thesicktimes.org · 02/09/2026
Want to stay on top of breaking Long COVID news? Sign up for The Sick Times newsletter and we'll deliver our original reporting directly to your inbox! pages.viral-loops.com/share-the-si...
PROBE-PASC should represent part of a much larger national research effort — not the limit of our investment.

Karyn Bishof, COVID-19 Longhauler Advocacy Project
062
The Sick Times @thesicktimes.org · 02/09/2026
Updates include: * Context on past DOD medical research funding * Comments + slides from Michael Peluso’s presentation at the ISLC-PAIS conference * Comments from Long COVID advocates * And a closer look at first clinical trial in the series, which will test Pemgarda and hydroxychloroquine
Key points you should know:

A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant.
 
This DOD grant, through the Congressionally Directed Medical Research Programs (CDMRP), supports biomedical research for specific diseases and topics that Congress has designated as priorities. Past grants have supported research into cancer, tick-borne illnesses, traumatic brain injuries, and more.Key points you should know:

The first clinical trial in the series will test the monoclonal antibody Pemgarda, along with the immune-modulating drug hydroxychloroquine. The study will include arms with both drugs by themselves and the two in combination.
 
The funding shows the DOD’s interest in Long COVID, which research has shown affects the military. A 2023 CDMRP grant supported the clinical trial of the novel drug bezisterim for Long COVID.
181
The Sick Times @thesicktimes.org · 02/09/2026
On Friday, The Sick Times broke the news that the U.S. Department of Defense (DOD) is funding a new clinical trials program for Long COVID with an initial grant of $8 million. This week we have more reporting from Betsy Ladyzhets about PROBE-PASC. thesicktimes.org/2026/09/01/d...
ID: A view of the U.S. Pentagon building at night reflecting in the Potomac River. Five bright lights emit from the building like stars. The text reads, “The Sick Times. Department of Defense funds $8 million grant for Long COVID trials. The first study in a new mechanistic clinical trials program will test Pemgarda and hydroxychloroquine alone and in combination. By Betsy Ladyzhets. Reporting.”
22413